city New Delhi India covid-19 experts recommendations Coronavirus city New Delhi India

COVID-19: Expert panel seeks DCGI's nod to use hepatitis injection for phase 3 trial

Reading now: 692
www.livemint.com

New Delhi: The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19 patients, said a senior health ministry official on Wednesday.The senior government official said: "Domestic pharma giant Gufic Bioscience has submitted its application to DCGI for its permission to use Thymosin @-1 injection 1.6 mg on coronavirus patients.

Our subject experts committee reviewed it thoroughly and further recommended to the Drugs Controller General of India (DGCI) for its consideration."So far, Thymosin @-1 injection 1.6 mg has been used in the treatment of.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA